Please login to the form below

Not currently logged in
Email:
Password:

Microbiome

This page shows the latest Microbiome news and features for those working in and with pharma, biotech and healthcare.

Nestlé and Seres announce new partnership for C.diff microbiome therapeutic

Nestlé and Seres announce new partnership for C.diff microbiome therapeutic

The companies will jointly commercialise Seres’ investigational oral microbiome therapeutic in the US and Canada. ... The two companies are planning to jointly commercialise Seres’ investigational oral microbiome therapeutic SER-109 in the US and

Latest news

More from news
Approximately 9 fully matching, plus 10 partially matching documents found.

Latest Intelligence

  • The need for automation in healthcare The need for automation in healthcare

    The cost-efficiency and speed of this form of testing would lend itself well to microbiome-based health tracking.

  • Gut instincts lead Takeda to GI pipeline success Gut instincts lead Takeda to GI pipeline success

    Takeda’s strategy is to develop GI products that address the highest unmet needs, which includes projects across three novel platforms – gene therapy, microbiome and cell therapy.

  • A snapshot of Microbiotica A snapshot of Microbiotica

    How is Microbiotica advancing life sciences with its technology? Microbiotica is a leading expert in the microbiome and is using its technology to identify the good and bad microbiomes in patients. ... There is also a $534m collaboration with Roche’s

  • Pharma’s coral reef Pharma’s coral reef

    If you need another example, look in the mirror and consider that a large part of the creature facing you is made of other organisms, such as those in your microbiome.

  • Deal Watch November 2016 Deal Watch November 2016

    immuno-oncology collaboration based on Enterome's microbiome technology.

More from intelligence
Approximately 0 fully matching, plus 9 partially matching documents found.

Latest appointments

  • Former Genzyme group vice president joins Vedanta Biosciences Former Genzyme group vice president joins Vedanta Biosciences

    His experience and leadership in pioneering new drug modalities will be invaluable as we advance our pipeline of microbiome-modulating therapies.”. ... Dr Roberts said: “Microbiome modulation is among the most exciting and rapidly evolving fields in

  • Vedanta Biosciences appoints two new heads Vedanta Biosciences appoints two new heads

    Vedanta is advancing a pipeline of product candidates designed to treat autoimmune, inflammatory and infectious diseases using technology that mines the human microbiome for potent pharmaceutical products.

  • Ritter Pharmaceuticals appoints new CMO Ritter Pharmaceuticals appoints new CMO

    Ritter is currently developing novel therapeutic products that modulate the human gut microbiome to treat gastrointestinal diseases. ... microbiome. “I believe my experience in product development coupled with my research capabilities will be a great

More from appointments
Approximately 0 fully matching, plus 3 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 0 fully matching, plus 2 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Jet Off with Maloff Protect

Latest intelligence

Top 10 ways to leverage the Impetus InSite Platform® to (virtually) launch your brand
The Impetus InSite Platform® can be used to facilitate virtual and hybrid engagement at all stages of the product lifecycle. Here, we share 10 of the most popular ways to...
Employee wellbeing in creative agencies: three tips to get you started
Paul Hutchings, founder of fox&cat, and new friend, Welfy, a workplace wellbeing training firm, discuss the importance of collaboration...
Managing unhelpful pressure in your creative agency: the human approach
Paul Hutchings, founder of fox&cat, answers the questions: what does it mean to be human in 2021? Are we putting ourselves under too much pressure?...